Risk of opportunistic infection in kidney transplant recipients with cytomegalovirus infection and associated outcomes
暂无分享,去创建一个
B. Astor | Neetika Garg | D. Mandelbrot | Jeannina A Smith | M. Jorgenson | J. Descourouez | B. Cardinale | B. Lyu | Christopher M Saddler
[1] Deepali Kumar,et al. Cytomegalovirus infection and graft rejection as risk factors for pneumocystis pneumonia in solid organ transplant recipients: A systematic review and meta‐analysis , 2018, Clinical transplantation.
[2] G. Verleden,et al. Determinants of the Magnitude of Interaction Between Tacrolimus and Voriconazole/Posaconazole in Solid Organ Recipients , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[3] C. Ensor,et al. Effects of Isavuconazole on the Plasma Concentrations of Tacrolimus among Solid-Organ Transplant Patients , 2017, Antimicrobial Agents and Chemotherapy.
[4] Su Hwan Lee,et al. Risk factors for Pneumocystis jirovecii pneumonia (PJP) in kidney transplantation recipients , 2017, Scientific Reports.
[5] F. Elzein,et al. Strongyloides Hyperinfection Syndrome Combined with Cytomegalovirus Infection , 2016, Case reports in transplantation.
[6] N. Kamar,et al. Pneumocystis Pneumonia in Solid-Organ Transplant Recipients , 2015, Journal of fungi.
[7] J. Schold,et al. CMV Viremia Is Associated With a Decreased Incidence of BKV Reactivation after Kidney and Kidney-Pancreas Transplantation , 2013, Transplantation.
[8] Y. Solak,et al. Cytomegalovirus and Aspergillus spp. coinfection in organ transplantation: a case report and review of the literature , 2012, CEN Case Reports.
[9] A. Berger,et al. A Pneumocystis jirovecii pneumonia outbreak in a single kidney-transplant center: role of cytomegalovirus co-infection , 2012, European Journal of Clinical Microbiology & Infectious Diseases.
[10] A. Åsberg,et al. Incidence and Outcomes of Ganciclovir-Resistant Cytomegalovirus Infections in 1244 Kidney Transplant Recipients , 2011, Transplantation.
[11] S. Nasiri,et al. Lack of cytomegalovirus and polyomavirus coexistence in Iranian kidney transplant recipients. , 2011, Transplantation proceedings.
[12] E. Dodds-Ashley. Management of Drug and Food Interactions with Azole Antifungal Agents in Transplant Recipients , 2010, Pharmacotherapy.
[13] A. Åsberg,et al. Effects of the Intensity of Immunosuppressive Therapy on Outcome of Treatment for CMV Disease in Organ Transplant Recipients , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[14] P. Carver,et al. Factors Influencing the Magnitude and Clinical Significance of Drug Interactions Between Azole Antifungals and Select Immunosuppressants , 2006, Pharmacotherapy.
[15] D. Correa,et al. Acute infection of Toxoplasma gondii and cytomegalovirus reactivation in a pediatric patient receiving liver transplant , 2006, Transplant infectious disease : an official journal of the Transplantation Society.
[16] S. Jordan,et al. Co-infection of Polyomavirus-BK and Cytomegalovirus in Renal Transplant Recipients , 2005, Transplantation.
[17] M. Boeckh,et al. High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection. , 2002, The Journal of infectious diseases.
[18] R. Rubin,et al. Infection in organ-transplant recipients. , 1998, The New England journal of medicine.
[19] D. Snydman,et al. The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc. Gaithersburg, Maryland. , 1997, The American journal of medicine.
[20] R. Rubin,et al. Infection in the renal transplant recipient. , 1981, The American journal of medicine.
[21] J. Moorhead,et al. Infection in the Renal Transplant Patient , 1978, Journal of the Royal Society of Medicine.
[22] 이수환. Risk factors for Pneumocystis jirovecii pneumonia (PJP) in kidney transplantation recipients , 2017 .
[23] P. Meylan,et al. Recurrent cytomegalovirus disease, visceral leishmaniosis, and Legionella pneumonia after liver transplantation: a case report , 2004, Canadian journal of anaesthesia = Journal canadien d'anesthesie.
[24] R. Rubin,et al. Clinical Approach to Infection in the Compromised Host , 2002, Springer US.
[25] R. Rubin. Infection in the Organ Transplant Recipient , 1994 .